ライフサイエンスコーパス: directly observed therapy

1 sis, confirming the efficacy of intermittent directly observed therapy.

2 ended by the World Health Organization under directly observed therapy.

3 11-5.43) were less likely to receive IPTp by directly observed therapy.

4 ecause of improved access to health care and directly observed therapy.

5 onadherence and should have been assigned to directly observed therapy.

6 antituberculosis therapy using intermittent directly observed therapy.

7 otal of 150 patients were ordered to undergo directly observed therapy, 139 patients to be detained d

8 Directly observed therapy also appears to be cost-effect

9 trol measures in the homeless should include directly observed therapy and incentive approaches, trea

10 Additional innovative models include directly observed therapy and peer-based models.

11 rvised strategies and modified approaches to directly observed therapy, are unlikely to achieve this

12 Patients treated by directly observed therapy at the start of therapy (n = 1

13 This study shows that in a directly observed therapy-based MDR tuberculosis program

14 Directly observed therapy coverage increased from 74% to

15 model to estimate the cost-effectiveness of directly observed therapy (DOT) for individuals with new

16 The use of directly observed therapy (DOT) for nearly all cases of

17 To determine the incremental cost of directly observed therapy (DOT) for patients with tuberc

18 PrEP was administered to women through daily directly observed therapy (DOT) for ten consecutive days

19 We evaluated the superiority of directly observed therapy (DOT) for tuberculosis patient

20 zid and rifapentine (3HP) administered under directly observed therapy (DOT) might increase treatment

21 eighborhood-specific rates of application of directly observed therapy (DOT).

22 Directly observed therapy (DOTS) is the main strategy fo

23 conclude that treatment plans that emphasize directly observed therapy from the start of therapy have

24 ly assigned 259 participants to the modified directly observed therapy group (n=129) or the standard-

25 34 (26%) participants in the modified directly observed therapy group achieved the primary end

26 was 25.1% (95% CI 17.7-32.4) in the modified directly observed therapy group and 17.3% (10.8-23.7) in

27 laboratory abnormality (n=21 in the modified directly observed therapy group and n=15 in the standard

28 Partner-based training with modified directly observed therapy had no effect on virological s

29 ment, good cooperation between services, and directly observed therapy improved treatment outcome and

30 nd tolerability of 12 weeks of INH/RPT given directly observed therapy in 17 consecutive SOT candidat

31 on receiving some portion of treatment under directly observed therapy increased from 27.3% to 59.1%

32 To improve adherence and cure rates, directly observed therapy is recommended for the treatme

33 randomized trial of a partner-based modified directly observed therapy (mDOT) compared with standard

34 l measures such as uniform implementation of directly observed therapy might reduce the proportion of

35 fference in standard of care versus modified directly observed therapy of -6.6% (95% CI -16.5% to 3.2

36 omisation, to receive partner-based modified directly observed therapy or standard of care.

37 standardized dosing, which is prescribed in directly observed therapy programs.

38 use of case management strategies (including directly observed therapy), regimen and dosing selection

39 didates, combination INH/RPT weekly given as directly observed therapy seems to be reasonably well to

40 s, driven by the World Health Organization's directly observed therapy, short course strategy.

41 gies to improve treatment adherence, such as directly observed therapy, should be used.

42 966 to August 1, 1996) with original data on directly observed therapy, supervised therapy, complianc

43 As compared with patients ordered to receive directly observed therapy, the patients who were detaine

44 003), and cavitary disease in the absence of directly observed therapy throughout therapy (OR, 2.65;

45 e more often, and were less likely to accept directly observed therapy voluntarily.

46 nd the less restrictive measure of mandatory directly observed therapy was often effective.

47 s based on a patient-centered approach using directly observed therapy with multiple enablers and enh

48 ner-based support intervention with modified directly observed therapy would improve outcomes with se